Brainsway (BWAY) Non-Current Debt (2018)
Brainsway (BWAY) posted quarterly Non-Current Debt of $2.1 million for Q4 2018.
Brainsway (BWAY) Non-Current Debt (2018) Analysis & Trends
Brainsway (BWAY) has reported Non-Current Debt for 1 consecutive years, with $2.1 million the latest figure, recorded in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 2.08 Mn |